La Jolla Pharmaceutical Company ( LJPC) - Stock Earnings

LJPC Quarterly earnings

DateEarningsRevenue
2021Q3 -2.3 million USD 13.3 million USD
2021Q4 3.8 million USD 12.2 million USD
2022Q1 2000 USD 10.4 million USD

LJPC Yearly earnings

DateEarningsRevenue
2019 -116.5 million USD 23.1 million USD
2020 -39.4 million USD 33.4 million USD
2021 19.7 million USD 75.7 million USD

LJPC

Price: $6.19

52 week price:
3.07
6.24

Earnings Per Share: 0.29 USD

P/E Ratio: 38.78

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 59664

Ebitda: -26.2 million

Market Capitalization: 171.2 million

Links: